Annual SG&A
$0.00$249.75M-100.00%
Summary
- Current Value
- As of today, RPRX annual SG&A is $0.00, down -100.00% on
- Historical Performance
- RPRX annual SG&A is down -100.00% over the past 3 years, and down -100.00% over the past 5 years
- All-Time High Comparison
- RPRX annual SG&A is currently -100.00% below its historical high of $249.75M set on
- 3-Year Low Comparison
- RPRX annual SG&A vs 3-year low value is unknown
- Sector Comparison
- RPRX annual SG&A is higher than 39.37% of companies in Healthcare sector
SG&A Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual SG&A | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| Quarterly SG&A | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| TTM SG&A | $9.85B | +4220.1% | +4824.8% | +6271.1% | +10000.0% | |
| Price | $40.26 | +36.5% | +2.7% | -18.6% | – | |
| Annual Operating Expenses | -$1.29B | +13.4% | -254.6% | +50.7% | -62.7% | |
| Annual Operating Profit | $1.29B | -13.4% | -9.7% | -50.7% | +62.7% | |
| Annual D&A | $0.00 | 0.0% | -100.0% | -100.0% | – | |
| Annual Revenue | $2.26B | -3.9% | -1.1% | +24.8% | +37.0% |
SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $249.75M | -100.0% | |
| 5Y | $249.75M | -100.0% | |
| All | $249.75M | -100.0% |
SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $0.00 | N/A | |
| 5Y | $0.00 | N/A | |
| All | $0.00 | N/A |
SG&A History
| Year | Value | Change |
|---|---|---|
| $0.00 | -100.0% | |
| $249.75M | +9.9% | |
| $227.30M | +24.3% | |
| $182.83M | +0.6% | |
| $181.72M | +75.7% |
| Year | Value | Change |
|---|---|---|
| $103.44M | +67.1% | |
| $61.91M | -41.8% | |
| $106.44M | +53.1% | |
| $69.51M | -42.7% | |
| $121.42M | - |
FAQ
What is the current annual SG&A of RPRX?
As of today, RPRX annual SG&A is $0.00
What is 1-year change in RPRX annual SG&A?
RPRX annual SG&A is down -100.00% year-over-year
What is 3-year change in RPRX annual SG&A?
RPRX annual SG&A is down -100.00% over the past 3 years
How far is RPRX annual SG&A from its all-time high?
RPRX annual SG&A is currently -100.00% below its historical high of $249.75M set on December 31, 2023
How does RPRX annual SG&A rank versus sector peers?
RPRX annual SG&A is higher than 39.37% of companies in Healthcare sector
When is RPRX next annual earnings release?
The next annual earnings release for RPRX is on
Quarterly SG&A
$0.00$179.77M-100.00%
Summary
- Current Value
- As of today, RPRX quarterly SG&A is $0.00, down -100.00% on
- Historical Performance
- RPRX quarterly SG&A is down -100.00% year-over-year, and down -100.00% over the past 3 years
- All-Time High Comparison
- RPRX quarterly SG&A is currently -100.00% below its historical high of $179.77M set on
- 3-Year Low Comparison
- RPRX quarterly SG&A vs 3-year low value is unknown
- Sector Comparison
- RPRX quarterly SG&A is higher than 45.89% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly SG&A | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| Annual SG&A | $0.00 | – | -100.0% | -100.0% | -100.0% | |
| TTM SG&A | $9.85B | +2273.2% | +4220.1% | +4824.8% | +6271.1% | |
| Price | $40.26 | +11.8% | +36.5% | +2.7% | -18.6% | |
| Quarterly Operating Expenses | $180.86M | +186.2% | +124.6% | +194.1% | +135.4% | |
| Quarterly Operating Profit | $427.16M | +103.6% | -41.9% | +122.2% | -16.3% | |
| Quarterly D&A | $1.28M | – | – | +100.0% | -78.0% | |
| Quarterly Revenue | $609.29M | +5.3% | +7.9% | +6.3% | +13.2% |
Quarterly SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $179.77M | -100.0% | |
| 3Y | $179.77M | -100.0% | |
| 5Y | $179.77M | -100.0% | |
| All | $179.77M | -100.0% |
Quarterly SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $0.00 | N/A | |
| 3Y | $0.00 | N/A | |
| 5Y | $0.00 | N/A | |
| All | $0.00 | N/A |
Quarterly SG&A History
FAQ
What is the current quarterly SG&A of RPRX?
As of today, RPRX quarterly SG&A is $0.00
What is RPRX quarterly SG&A most recent change?
RPRX quarterly SG&A was down -100.00% on September 30, 2025
What is 1-year change in RPRX quarterly SG&A?
RPRX quarterly SG&A is down -100.00% year-over-year
How far is RPRX quarterly SG&A from its all-time high?
RPRX quarterly SG&A is currently -100.00% below its historical high of $179.77M set on June 30, 2025
How does RPRX quarterly SG&A rank versus sector peers?
RPRX quarterly SG&A is higher than 45.89% of companies in Healthcare sector
When is RPRX next earnings release?
The next earnings release for RPRX is on
TTM SG&A
$9.85B$460.37M-4.46%
Summary
- Current Value
- As of today, RPRX TTM SG&A is $9.85B, down -4.46% on
- Historical Performance
- RPRX TTM SG&A is up +4220.14% year-over-year, and up +4824.84% over the past 3 years
- All-Time High Comparison
- RPRX TTM SG&A is currently -5.88% below its historical high of $10.47B set on an earlier date
- 3-Year Low Comparison
- RPRX TTM SG&A is +14.99% above its 3-year low of $8.57B reached on an earlier date
- Sector Comparison
- RPRX TTM SG&A is higher than 94.20% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM SG&A | $9.85B | +2273.2% | +4220.1% | +4824.8% | +6271.1% | |
| Annual SG&A | $0.00 | – | -100.0% | -100.0% | -100.0% | |
| Quarterly SG&A | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| Price | $40.26 | +11.8% | +36.5% | +2.7% | -18.6% | |
| TTM Operating Profit | $1.53B | -16.7% | -0.8% | +62.5% | -41.4% | |
| TTM D&A | $1.28M | – | – | -88.9% | -94.5% | |
| TTM Revenue | $2.35B | +1.9% | +3.7% | +4.6% | +17.1% |
TTM SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $10.47B | N/A | -5.9% |
| 3Y | $10.47B | N/A | -5.9% |
| 5Y | $10.47B | N/A | -5.9% |
| All | $10.47B | N/A | -5.9% |
TTM SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $9.85B | N/A | at low |
| 3Y | $8.57B | N/A | +15.0% |
| 5Y | $7.22B | N/A | +36.4% |
| All | $2.83B | N/A | +248.8% |
TTM SG&A History
FAQ
What is the current TTM SG&A of RPRX?
As of today, RPRX TTM SG&A is $9.85B
What is RPRX TTM SG&A most recent change?
RPRX TTM SG&A was down -4.46% on September 30, 2025
What is 1-year change in RPRX TTM SG&A?
RPRX TTM SG&A is up +4220.14% year-over-year
How does RPRX TTM SG&A rank versus sector peers?
RPRX TTM SG&A is higher than 94.20% of companies in Healthcare sector
When is RPRX next earnings release?
The next earnings release for RPRX is on
Selling, General & Administrative Expenses Formula
SG&A = − − R&D
Data Sources & References
- RPRX Official Website www.royaltypharma.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1802768/000180276825000114/0001802768-25-000114-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1802768/000180276825000010/0001802768-25-000010-index.htm
- RPRX Profile on Yahoo Finance finance.yahoo.com/quote/RPRX
- RPRX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rprx